Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Wightman

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current HIV/AIDS Reports|January 18, 2012
HIV reservoirs and strategies for eradicationMiranda Z Smith, Fiona Wightman, Sharon R Lewin
Immunology and Cell Biology|November 16, 2011
HDAC inhibitors in HIVFiona Wightman, Paula Ellenberg, Melissa Churchill, et al.
Journal of Virological Methods|September 8, 2004
Highly reproducible transient transfections for the study of hepatitis B virus replication based on an internal GFP reporter systemTheo Gouskos, Fiona Wightman, Sharon R Lewin, et al.
Current Opinion in HIV and AIDS|September 9, 2016
Cancer therapies in HIV cure researchThomas A Rasmussen, Jenny L Anderson, Fiona Wightman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Enhanced replicative capacity and pathogenicity of HIV-1 isolated from individuals infected with drug-resistant virus and declining CD4+ T-cell countsAjantha Solomon, Natalie Lane, Fiona Wightman, et al.
Blood|September 21, 2007
CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latencySuha Saleh, Ajantha Solomon, Fiona Wightman, et al.
AIDS (London, England)|July 29, 2004
Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patientTheo Gouskos, Fiona Wightman, Judy Chang, et al.
Journal of Virology|February 15, 2005
Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapyJ Judy Chang, Fiona Wightman, Angeline Bartholomeusz, et al.
Journal of Clinical Microbiology|August 7, 2004
Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strainsFiona Wightman, Tomos Walters, Anna Ayres, et al.
Human Vaccines & Immunotherapeutics|February 2, 2013
Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activationThomas Aagaard Rasmussen, Ole Schmeltz Søgaard, Christel Brinkmann, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current HIV/AIDS Reports|January 18, 2012
HIV reservoirs and strategies for eradicationMiranda Z Smith, Fiona Wightman, Sharon R Lewin
Immunology and Cell Biology|November 16, 2011
HDAC inhibitors in HIVFiona Wightman, Paula Ellenberg, Melissa Churchill, et al.
Journal of Virological Methods|September 8, 2004
Highly reproducible transient transfections for the study of hepatitis B virus replication based on an internal GFP reporter systemTheo Gouskos, Fiona Wightman, Sharon R Lewin, et al.
Current Opinion in HIV and AIDS|September 9, 2016
Cancer therapies in HIV cure researchThomas A Rasmussen, Jenny L Anderson, Fiona Wightman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Enhanced replicative capacity and pathogenicity of HIV-1 isolated from individuals infected with drug-resistant virus and declining CD4+ T-cell countsAjantha Solomon, Natalie Lane, Fiona Wightman, et al.
Blood|September 21, 2007
CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latencySuha Saleh, Ajantha Solomon, Fiona Wightman, et al.
AIDS (London, England)|July 29, 2004
Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patientTheo Gouskos, Fiona Wightman, Judy Chang, et al.
Journal of Virology|February 15, 2005
Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapyJ Judy Chang, Fiona Wightman, Angeline Bartholomeusz, et al.
Journal of Clinical Microbiology|August 7, 2004
Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strainsFiona Wightman, Tomos Walters, Anna Ayres, et al.
Human Vaccines & Immunotherapeutics|February 2, 2013
Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activationThomas Aagaard Rasmussen, Ole Schmeltz Søgaard, Christel Brinkmann, et al.
Pageof 3